AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,004,021 Value ($000) $12,129 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 1,107,008 Value ($000) $15,044 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 1,154,485 Value ($000) $7,400 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 1,199,691 Value ($000) $4,247 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 1,263,353 Value ($000) $4,775 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 880,745 Value ($000) $2,854 Avg Close $2.25 Range $1.62 - $3.33
Q2 2024
Shares 621,927 Value ($000) $1,182 Avg Close $1.94 Range $1.57 - $2.89
Q1 2024
Shares 526,688 Value ($000) $1,496 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 256,606 Value ($000) $3,777 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 124,455 Value ($000) $2,279 Avg Close $21.15 Range $17.80 - $25.48